_PRIVATE_LIMITED.webp)
Mediscribe (India) Profile
Key Indicators
- Authorised Capital ₹ 2.40 M
- Paid Up Capital ₹ 2.40 M
- Company Age 25 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.50 M
- Revenue Growth -6.50%
- Profit Growth -408.09%
- Ebitda -375.47%
- Net Worth -7.42%
- Total Assets -2.91%
About Mediscribe (India)
Mediscribe (India) Private Limited (MIPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 March 1999 and has a history of 25 years and ten months. Its registered office is in Bangalore., Karnataka, India.
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.40 M and a paid-up capital of Rs 2.40 M.
The company currently has active open charges totaling ₹8.50 M.
Prakash Shantilal, Rajani Tukol, Kavitha Prakash, and One other member serve as directors at the Company.
Company Details
-
Location
Bangalore., Karnataka, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U72300KA1999PTC024942
-
Company No.
024942
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Mar 1999
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
What products or services does Mediscribe (India) Private Limited offer?
Mediscribe (India) Private Limited offers a wide range of products and services, including Language Translators & Interpreter, Transcription Services, Medical Consultants & Clinics, Medical Consultancy Services, Business Planning and Management, Business Consultant.
Who are the key members and board of directors at Mediscribe (India)?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prakash Shantilal
|
Director | 22-Mar-1999 | Current |
|
Rajani Tukol
|
Director | 01-Apr-2009 | Current |
|
Kavitha Prakash
|
Director | 01-Apr-2009 | Current |
|
Pradeep Shanthilal
|
Director | 22-Mar-1999 | Current |
Financial Performance of Mediscribe (India).
Mediscribe (India) Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.5% decrease. The company also saw a substantial fall in profitability, with a 408.09% decrease in profit. The company's net worth dipped by a decrease of 7.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mediscribe (India)?
In 2022, Mediscribe (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Atria Clinical Research India Private LimitedPrakash Shantilal, Kavitha Prakash and 1 more are mutual person
Charges (Loans)
₹8.50 M
₹0
Charges Breakdown by Lending Institutions
- Karnataka Bank Ltd. : 0.85 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Mar 2022 | Karnataka Bank Ltd. | ₹8.50 M | Open |
How Many Employees Work at Mediscribe (India)?
Mediscribe (India) has a workforce of 11 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mediscribe (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediscribe (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
